Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Protagenic Therapeutics Inc
(NQ:
PTIX
)
1.280
-0.100 (-7.25%)
Streaming Delayed Price
Updated: 3:09 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,837
Open
1.340
Bid (Size)
1.280 (9)
Ask (Size)
1.340 (11)
Prev. Close
1.380
Today's Range
1.280 - 1.340
52wk Range
0.6797 - 2.320
Shares Outstanding
4,435,132
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
May 01, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
Performance
YTD
+39.13%
+39.13%
1 Month
-21.95%
-21.95%
3 Month
+31.96%
+31.96%
6 Month
+58.99%
+58.99%
1 Year
-33.33%
-33.33%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 23, 2024
Via
Benzinga
Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
April 17, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
April 01, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
March 27, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
March 25, 2024
Via
ACCESSWIRE
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023
April 01, 2024
Via
InvestorPlace
Earnings Scheduled For April 1, 2024
April 01, 2024
Via
Benzinga
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
March 21, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
February 13, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
September 26, 2023
Via
ACCESSWIRE
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split
March 22, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 04, 2023
Via
Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 01, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 21, 2022
Via
InvestorPlace
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.